Atopic Dermatitis and Prurigo Nodularis: The Impact of Chronic Itch
CE Information
0.5 contact hours (0.5 pharmacology)Completion Time
30 minutesAvailable Until
May 14, 2026Posted By
NP Events
Navigate
Overview
Specialties
Acute Care, Adult, Family, Gerontological, and PediatricSubspecialties
Allergy/Immunology and DermatologyClinical Topics
Allergies and Dermatologic DiseaseTarget Audience
This educational activity is intended for dermatology nurse practitioners and physician associates, as well as those practicing in primary care, who are engaged in the care of patients with atopic dermatitis and prurigo nodularis.
Program Learning Goal
The goal of this activity is to improve the knowledge, competence, and performance of learners in effort to optimize treatment for patients with Atopic Dermatitis
Learning Objectives
Upon completion of this activity, participants should be able to:
-
Describe the impact of pruritus on the overall burden of living with AD and PN, highlighting its effects on patient quality of life, disease progression, and the challenges in effective management
-
Incorporate evidence-based tools for the measurement and assessment of itch into clinical practice to enhance patient care and treatment outcomes
-
Develop treatment plans for patients with AD and PN that take into consideration evidence for new and emerging therapies targeting neuroinflammation and itch
Speakers
Director
Lahey Dermatology Nurse Practitioner Training Program
Lahey Hospital and Medical Center
Burlington, Massachusetts
Assistant Professor
Emory University PA Program
Atlanta, Georgia
Director, Skin of Color Division
Dr. Philip Frost Department of Dermatology and Cutaneous Surgery
University of Miami Miller School of Medicine
Miami, Florida
Heather Woolery-Lloyd, MD is a board-certified dermatologist and board certified in Lifestyle Medicine. She completed her undergraduate studies at Georgetown University and later earned her medical degree at the University of Miami School of Medicine. She completed her training in dermatology at the University of Miami where she also served as chief resident. Dr. Woolery-Lloyd is an internationally recognized dermatology and wellness expert. She has lectured at national and international conferences on anti-aging strategies in skincare and wellness. She is the founder of DermFriends, a platform that provides a reliable source of dermatology and skincare education, and expert recommendations for common skin, hair, and nail concerns.
CE Information
This activity offers 0.5 contact hours (0.5 pharmacology) to attendees.
Accredited by ANCC.
Disclosures
Partners for Advancing Clinical Education (Partners) requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Partners policies. Others involved in the planning of this activity have no relevant financial relationships.
Primary Author
Victoria Garcia-Albea, PNP, DCNP: consultant/advisor/speaker: Dermavant, Johnson & Johnson, Sanofi/Genzyme, Sun Pharma, UCB.
Martha L. Sikes, DMSc, RPh, PA-C: consultant/advisor/speaker: Ortho Dermatologics.
Heather Woolery-Lloyd, MD: consultant/advisor/speaker: AbbVie, Arcutis, Beiersdorf, Galderma, Incyte, Kenvue, Loreal, Ortho Dermatologics, Pfizer, Proctor and Gamble, SC Johnson, Unilever; researcher: AbbVie, Allergan, Arcutis, Avita, Eirion, Galderma, Pfizer, Teoxane Laboratories.
Kelly Barta: consultant/advisor/speaker: Astria Therapeutics
Brindley Brooks: other financial or material support: Incyte, Lilly, Moonlake, Novartis, Sanofi, UCB
Register For This Activity
OnDemand Activity Registration
Select this option to access the activity at no cost.